COSCIENS Biopharma Statistics

Total Valuation

TSX:CSCI has a market cap or net worth of CAD 14.00 million. The enterprise value is -6.26 million.

Market Cap	14.00M
Enterprise Value	-6.26M

Important Dates

The last earnings date was Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CSCI has 3.15 million shares outstanding. The number of shares has increased by 39.74% in one year.

Current Share Class	n/a
Shares Outstanding	3.15M
Shares Change (YoY)	+39.74%
Shares Change (QoQ)	+1.09%
Owned by Insiders (%)	1.47%
Owned by Institutions (%)	0.68%
Float	2.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.01
PB Ratio	0.74
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.28

Financial Position

The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.18.

Current Ratio	3.32
Quick Ratio	2.61
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-77.07

Financial Efficiency

Return on equity (ROE) is -89.54% and return on invested capital (ROIC) is -32.53%.

Return on Equity (ROE)	-89.54%
Return on Assets (ROA)	-21.13%
Return on Invested Capital (ROIC)	-32.53%
Return on Capital Employed (ROCE)	-35.70%
Revenue Per Employee	344,854
Profits Per Employee	-550,680
Employee Count	40
Asset Turnover	0.33
Inventory Turnover	1.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.21% in the last 52 weeks. The beta is 2.27, so TSX:CSCI's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	-59.21%
50-Day Moving Average	4.16
200-Day Moving Average	5.11
Relative Strength Index (RSI)	56.94
Average Volume (20 Days)	1,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CSCI had revenue of CAD 13.79 million and -22.03 million in losses. Loss per share was -8.53.

Revenue	13.79M
Gross Profit	6.80M
Operating Income	-14.30M
Pretax Income	-21.91M
Net Income	-22.03M
EBITDA	-12.49M
EBIT	-14.30M
Loss Per Share	-8.53

Full Income Statement

Balance Sheet

The company has 23.59 million in cash and 3.32 million in debt, giving a net cash position of 20.26 million or 6.44 per share.

Cash & Cash Equivalents	23.59M
Total Debt	3.32M
Net Cash	20.26M
Net Cash Per Share	6.44
Equity (Book Value)	18.94M
Book Value Per Share	6.03
Working Capital	24.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.96 million and capital expenditures -1.67 million, giving a free cash flow of -22.63 million.

Operating Cash Flow	-20.96M
Capital Expenditures	-1.67M
Free Cash Flow	-22.63M
FCF Per Share	-7.19

Full Cash Flow Statement

Margins

Gross margin is 49.33%, with operating and profit margins of -103.70% and -159.68%.

Gross Margin	49.33%
Operating Margin	-103.70%
Pretax Margin	-158.81%
Profit Margin	-159.68%
EBITDA Margin	-90.52%
EBIT Margin	-103.70%
FCF Margin	n/a

Dividends & Yields

TSX:CSCI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.74%
Shareholder Yield	-39.74%
Earnings Yield	-157.33%
FCF Yield	-161.65%

Stock Splits

The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25.

Last Split Date	May 3, 2024
Split Type	Reverse
Split Ratio	0.25

Scores

TSX:CSCI has an Altman Z-Score of -0.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.23
Piotroski F-Score	n/a